Evaluation of the Early Results of Percutaneous Ethanol Ablation in Patients with Primary Hyperparathyroidism
Percutaneous ethanol ablation (PEA) is an alternative non-surgical method for the treatment of patients with primary hyperparathyroidism (PHPT), suitable in cases with comorbidities and high surgical risk.
Main Authors: | Yankova I., Shinkov A., Kovatcheva R. |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2022-04-01
|
Series: | Acta Medica Bulgarica |
Subjects: | |
Online Access: | https://doi.org/10.2478/amb-2022-0001 |
Similar Items
-
Ultrasound-guided ethanol injection for the treatment of parathyroid adenoma: A prospective self-controlled study
by: Amir Ali Yazdani, et al.
Published: (2020-01-01) -
Case report: Microwave ablation is a safe and effective method for primary hyperparathyroidism in pregnancy
by: Yunbo Luo, et al.
Published: (2024-01-01) -
Primary Hyperparathyroidism: Modern Conception and Clinical Observation
by: L. M. Farkhutdinova
Published: (2020-03-01) -
Parathyroid adenoma in children: A rare cause of primary hyperparathyroidism
by: Srotaswini Roy, et al.
Published: (2024-01-01) -
A Case of Primary Hyperparathyroidism Secondary to Parathyroid Adenoma in a Pediatric Patient
by: Gannon J. Ray, MD, et al.
Published: (2024-05-01)